⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16556580 | 1.00 | — | — | |
| SCHEMBL30055070 | 0.89 | HTR6 (0.64) | — | |
| SCHEMBL9558262 | 0.87 | HTR6 (0.68) | — | |
| SCHEMBL5935271 | 0.87 | HTR6 (0.68) | — | |
| SCHEMBL337087 | 0.86 | HTR6 (0.65) | — | |
| SCHEMBL10758546 | 0.85 | — | — | |
| SCHEMBL336731 | 0.85 | — | — | |
| SCHEMBL13835419 | 0.85 | — | — | |
| SCHEMBL271886 | 0.85 | — | — | |
| SCHEMBL63706 | 0.85 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 425 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3442977-B1 | INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE | BLUEPRINT MEDICINES CORP (US) | 2023-06-28 | — | — | EP | claimed |
| US-20190248715-A1 | Compositions and Methods for Coating of Nitrification Inhibitors with a Solution Containing a High Concentration of Urease Inhibitors and For Improved Retention of the Nitrogen Content of Soil Through the Administration of Liquid Delivery Formulations of (Aminomethylene)Phosphinic Acids and/or their Salts | SOILGENIC TECHNOLOGIES, LLC | 2019-08-15 | — | — | US | claimed |
| US-7204997-B2 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2007-04-17 | — | — | US | claimed |
| EP-1478403-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA, INC. (CA) | 2004-11-24 | — | — | EP | claimed |
| US-20030152623-A1 | Responsive microgel and methods related thereto | SUPRATEK PHARMA INC. (CA) | 2003-08-14 | — | — | US | claimed |
| WO-2003063909-A1 | RESPONSIVE MICROGEL AND METHODS RELATED THERETO | SUPRATEK PHARMA INC. (US) | 2003-08-07 | — | — | WO | claimed |
| WO-1996002276-A9 | NOVEL POLYMER GEL NETWORKS AND METHODS OF USE | — | 1996-02-29 | — | — | WO | claimed |
| WO-1996002276-A2 | NOVEL POLYMER GEL NETWORKS AND METHODS OF USE | GEL SCIENCES, INC. (US) | 1996-02-01 | — | — | WO | claimed |
| US-4188474-A | OLIGOMERIC POLYETHYLENEPIPERAZINE | TEXACO DEVELOPMENT CORPORATION (US) | 1980-02-12 | — | — | US | claimed |
| US-4185149-A | OLIGOMERIC POLY(ETHYLENEPIPERAZINE) | TEXACO DEVELOPMENT CORPORATION (US) | 1980-01-22 | — | — | US | claimed |
| JP-4164077-A | — | — | None | — | — | JP | disclosed |
| US-20240239845-A1 | PRE-FUSION RSV F ANTIGENS | NOVARTIS AG (CH) | 2024-07-18 | — | — | US | disclosed |
| CN-110913903-B | Glycan interaction compounds and methods of use | 思进股份有限公司 | 2024-03-01 | — | — | CN | disclosed |
| US-20240050553-A1 | MAKING INFLUENZA VIRUS VACCINES WITHOUT USING EGGS | Seqirus UK Limited (GB) | 2024-02-15 | — | — | US | disclosed |
| US-20240034773-A1 | RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2024-02-01 | — | — | US | disclosed |
| US-4188474-A | OLIGOMERIC POLYETHYLENEPIPERAZINE | TEXACO DEVELOPMENT CORPORATION (US) | 1980-02-12 | — | — | US | disclosed |
| US-4185149-A | OLIGOMERIC POLY(ETHYLENEPIPERAZINE) | TEXACO DEVELOPMENT CORPORATION (US) | 1980-01-22 | — | — | US | disclosed |
| US-4185149-A | OLIGOMERIC POLY(ETHYLENEPIPERAZINE) | TEXACO DEVELOPMENT CORPORATION (US) | 1980-01-22 | — | — | US | disclosed |
| US-4066649-A | METHOD OF PRODUCING N,N'-(DIMETHYL) PIPERAZINE COMPOUNDS | TEXACO DEVELOPMENT CORPORATION (US) | 1978-01-03 | — | — | US | disclosed |
| US-3943135-A | ANTHELMINTIC | SANRAKU-OCEAN CO., LTD. (JA) | 1976-03-09 | — | — | US | disclosed |